Evidence map›Paper›PMID 25955964›Full record

ArticlePain2015

Behavioral and neurochemical analysis of ongoing bone cancer pain in rats.

Bethany Remeniuk, Devki Sukhtankar, Alec Okun, Edita Navratilova, Jennifer Y Xie, Tamara King, Frank Porreca

Abstract read
In one paragraph

Article in Pain, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Activation of the STING pathway induces peripheral sensitization via neuroinflammation in a rat model of bone cancer pain.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Mechanisms Underlying Bone and Joint Pain.Current osteoporosis reports · 2018
    Review
  15. Endogenous and Exogenous Opioids in Pain.Annual review of neuroscience · 2018
    Review
  16. Article
  17. Review
  18. Mediation of Movement-Induced Breakthrough Cancer Pain by IB4-Binding Nociceptors in Rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Bethany RemeniukDepartment of Cancer Biology, Arizona Cancer Center, University of Arizona, Tucson, AZ, USA Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA Department of Biomedical Sciences, College of Osteopathic Medicine, Center for Excellence in the Neurosciences, University of New England, Biddeford, ME, USA.
Devki Sukhtankar
Alec Okun
Edita Navratilova
Jennifer Y Xie
Tamara King
Frank Porreca
Christie's · GBUniversity of Arizona · USUniversity of New England · USFundación Juan March · ES

Funding

Tissue resident macrophages in sensory ganglia: function and impact on nociceptionP20GM103643 · NIGMS · UNIVERSITY OF NEW ENGLAND · PI MENG, IAN D · 2012 to 2021
$20.9M
Integrative Cancer Scholars Training GrantT32CA009213 · NCI · UNIVERSITY OF ARIZONA · PI CAREW, JENNIFER S, CURIEL-LEWANDROWSKI, CLARA · 1985 to 2024
$8.6M
Interdisciplinary Training in Biobehavioral Pain ResearchT32NS070201 · NINDS · JOHNS HOPKINS UNIVERSITY · PI DONG, XINZHONG, SMITH, MICHAEL T · 2010 to 2024
$3.6M
Brain reward circuits and relief of ongoing painR01DA034975 · NIDA · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2013 to 2017
$2.8M
Mechanisms of Spontaneous Neuropathic PainR01NS066958 · NINDS · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 2010 to 2014
$1.6M
NCI NIH HHS T32 CA009213NCI NIH HHS T32CA009213NIDA NIH HHS R01 DA034975NIGMS NIH HHS P20 GM103643NINDS NIH HHS R01 NS066958NINDS NIH HHS T32 NS070201
6 · The paper itself

Abstract

Cancer-induced bone pain is described as dull, aching ongoing pain. Ongoing bone cancer pain was characterized after intratibial injection of breast cancer cells in rats. Cancer produced time-dependent bone remodeling and tactile hypersensitivity but no spontaneous flinching. Conditioned place preference (CPP) and enhanced dopamine (DA) release in the nucleus accumbens (NAc) shell was observed after peripheral nerve block (PNB) selectively in tumor-bearing rats revealing nociceptive-driven ongoing pain. Oral diclofenac reversed tumor-induced tactile hypersensitivity but did not block PNB-induced CPP or NAc DA release. Tumor-induced tactile hypersensitivity, and PNB-induced CPP and NAc DA release, was blocked by prior subcutaneous implantation of a morphine pellet. In sham rats, morphine produced a modest but sustained increase in NAc DA release. In contrast, morphine produced a transient 5-fold higher NAc DA release in tumor bearing rats compared with sham morphine rats. The possibility that this increased NAc DA release reflected the reward of pain relief was tested by irreversible blockade of rostral anterior cingulate cortex (rACC) μ-opioid receptors (MORs). The rACC MOR blockade prevented the morphine-induced transient increased NAc DA release in tumor bearing rats but did not affect morphine-induced effects in sham-operated animals. Consistent with clinical experience, ongoing cancer pain was controlled by morphine but not by a dose of diclofenac that reversed evoked hypersensitivity. Additionally, the intrinsic reward of morphine can be dissociated from the reward of relief of cancer pain by blockade of rACC MOR. This approach allows mechanistic and therapeutic assessment of ongoing cancer pain with likely translation relevance.

Indexed as

AdenocarcinomaAnalgesics, OpioidAnesthetics, LocalAnimalsAnti-Inflammatory Agents, Non-SteroidalBehavior, AnimalBone NeoplasmsCell Line, TumorDiclofenacDisease Models, AnimalFemaleGyrus CinguliLidocaineMorphineNaltrexoneNarcotic AntagonistsAnalgesics, OpioidAnesthetics, LocalAnti-Inflammatory Agents, Non-Steroidalbeta-funaltrexamineDiclofenacLidocaineMorphineNaltrexoneNarcotic Antagonists

Identifiers

PMID25955964
PMCPMC4578982
OpenAlexW1424802244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.